[1]陈 相a,陶国华a,周 峰a,等.叉头框蛋白J2在非小细胞肺癌组织 和癌旁组织中的表达及临床意义[J].现代检验医学杂志,2016,31(03):95-97.[doi:10.3969/j.issn.1671-7414.2016.03.026]
　CHEN Xianga,TAO Guo-huaa,ZHOU Fenga,et al.Expression and Its Clinical Significance of Forkhead Box J2 in Non-small Cell Lung Cancer Tissues and Paracancerous Tissues[J].Journal of Modern Laboratory Medicine,2016,31(03):95-97.[doi:10.3969/j.issn.1671-7414.2016.03.026]
点击复制

叉头框蛋白J2在非小细胞肺癌组织 和癌旁组织中的表达及临床意义()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第31卷
期数:
2016年03期
页码:
95-97
栏目:
论著
出版日期:
2016-06-15

文章信息/Info

Title:
Expression and Its Clinical Significance of Forkhead Box J2 in Non-small Cell Lung Cancer Tissues and Paracancerous Tissues
文章编号:
1671-7414(2016)03-095-03
作者:
陈 相a; 陶国华a; 周 峰a; 赵 枰a; 杨其昌b; 沈 屹b; 曹兴建a
南通市第一人民医院a.医学检验科;
b.病理科,江苏南通 226001
Author(s):
CHEN Xianga; TAO Guo-huaa; ZHOU Fenga; ZHAO Pinga; YANG Qi-changb; SHEN Yib;  CAO Xing-jiana
a.Department of Clinical Laboratory;
b.Department of Pathology,the First People's Hospital of Nantong,Jiangsu Nantong 226001,China
关键词:
叉头框蛋白J2;  非小细胞肺癌;  免疫印迹;  免疫组化;  淋巴结转移
分类号:
R734.2; R730.43
DOI:
10.3969/j.issn.1671-7414.2016.03.026
文献标志码:
A
摘要:
目的 探讨叉头框蛋白J2(forkhead box J2,Foxj2)在非小细胞肺癌(non-small cell lung cancer,NSCLC)患者癌组织中的表达及其临床意义。方法 收集50例NSCLC患者手术切除肺癌组织标本,用免疫印迹法(western blot)和免疫组化法检测Foxj2在癌组织和癌旁组织中的表达。结果 western blot显示Foxj2在癌旁组织中的表达高于癌组织,两组间差异具有统计学意义(P<0.05); 免疫组化结果表明Foxj2在癌旁组织中的阳性细胞数明显高于癌组织,且无淋巴结转移组Foxj2的表达强度高于有淋巴结转移组,两组间差异具有统计学意义(P<0.01)。结论 Foxj2参与NSCLC的发生发展过程,并且可能与NSCLC淋巴结转移有关。
Abstract:
Objective To evaluate the expressions and its clinical significance of Foxj2 in non-small cell lung cancer(NSCLC)patients.Methods Fifty cancer tissues from patients who underwentsurgery were collected.Western blot and immunohistochemical methods were used to detect the expressions of Foxj2.Results Results of western blot showed that Foxj2 expression in lung cancer tissue was significantly lower than adjacent tissues.The difference between the two groups was statistically significant(P<0.05).Immunohistoehemical results showed that the number of Foxj2-positive cells in adjacent tissues was significantly higher than that in cancer tissues,and the expression of Foxj2 in non-lymphatic node metastasis group was higher than that in lymphatic node metastasis.The difference between the two groups was statistically significant(P<0.01).Conclusion The expressions and location of Foxj2 was related to the lymphatic node metastasis of lung cancer.This phenomenon indicates that Foxj2 may playan important role in the development of lung cancer.

参考文献/References:

[1] Chen W,Zheng R,Baade PD,et al.Cancer statistics in China,2015[J].CA Cancer J Clin,2016,66(2):115-132.
[2] 陈宗启.中西医结合治疗晚期非小细胞肺癌的临床应用进展[J].中医临床研究,2015,7(23):99-100. Chen ZQ.Areview on treating later period non-small cell lung cancer in the integrative medicine[J].Clinical Journal of Chinese Medicine,2015,7(23):99-100.
[3] Halasi M, Gartel AL. Targeting FOXM1 in cancer[J].Biochem Pharmacol,2013,85(5):644-652.
[4] Zhang Y,Xing Y,Zhang L,et al.Regulation of cell cycle progression byforkhead transcription factor FOXO3 through its binding partner DNA replicationfactor Cdt1[J].Proc Natl Acad Sci USA,2012,109(15):5717-5722.
[5] Zhou Y,Liang C,Xue F,et al.Salinomycin decreases doxorubicin resistance in hepatocellular carcinoma cells by inhibiting the β-catenin/TCF complex association via FOXO3a activation[J].Oncotarget,2015,6(12):10350-10365.
[6] Sahu B, Laakso M, Ovaska K,et al.Dual role of FoxA1 in androgen receptor binding to chromatin,androgen signalling and prostate cancer[J].EMBO J,2011,30(19):3962-3976.
[7] Du J,Li L,Ou Z,et al.FOXC1,a target of polycomb,inhibits metastasisof breast cancer cells[J].Breast Cancer Res Treat,2012,131(1):65-73.
[8] Mehta RJ,Jain RK,Leung S,et al.FOXA1 is an independent prognostic marker for ER-positive breast cancer[J].Breast Cancer Res Treat,2012,131(1):881-890.
[9] Zhang HY,Sun H.Up-regulation of Foxp3 inhibits cell proliferation,migration and invasion in epithelial ovarian cancer[J].Cancer Lett,2010,287(1):91-97.
[10] Wang Y,Yang S,Ni Q,et al.Overexpression of fo-rkhead box J2can decrease the migration of breast cancer cells[J].J Cell Biochem,2012,113(8):2729-2737.
[11] Chen X, Cao X, Tao G,et al.FOXJ2 expression in rat spinal cord afterinjury and its role in inflammation[J].J Mol Neurosci,2012,47(1):158-165.
[12] Paredes J,Figueiredo J,Albergaria A,et al.Epithelial E- and P-cadherins:role and clinical significance in cancer[J].Biochim Biophys Acta,2012,1826(2):297-311.
[13] Qiu X,Ji B,Yang L,et al.The role of FoxJ2 in the migration of humanglioma cells[J].Pathol Res Pract,2015,211(5):389-397.

相似文献/References:

[1]刘丽燕a,陈晓丹b,杨明夏c,等.外周血异常糖链糖蛋白检测对非小细胞肺癌患者治疗监测的意义[J].现代检验医学杂志,2017,32(01):103.[doi:10.3969/j.issn.1671-7414.2017.01.028]
　LIU Li-yana,CHEN Xiao-danb,YANG Ming-xiac,et al.Significance of Tumor Abnormal Protein in Peripheral Blood in the Therapeutic Monitoring of Non-Small Cell Lung Cancer[J].Journal of Modern Laboratory Medicine,2017,32(03):103.[doi:10.3969/j.issn.1671-7414.2017.01.028]
[2]张永庆a,尚立群a,苗 毅a,等.表皮生长因子受体基因突变与非小细胞肺癌病理的相关性分析[J].现代检验医学杂志,2017,32(06):78.[doi:10.3969/j.issn.1671-7414.2017.06.001]
　ZHANG Yong-qinga,SHANG Li-quna,MIAO Yia,et al.Analysis of the Correlation between Mutations of the Epidermal Growth Factor Receptor Gene and Pathological of Non Small Cell Lung Cancer[J].Journal of Modern Laboratory Medicine,2017,32(03):78.[doi:10.3969/j.issn.1671-7414.2017.06.001]
[3]喻 晶,李运雷,刘晓翌.非小细胞肺癌患者不同类型样本中表皮生长因子受体基因突变的差异研究[J].现代检验医学杂志,2018,33(04):31.[doi:10.3969/j.issn.1671-7414.2018.04.008]
　YU Jing,LI Yun-lei,LIU Xiao-yi.Detection of Epidermal Growth Factor Receptor Gene Mutation in Different Sample Types of 238 Patients with Non-small Cell Lung Cancer[J].Journal of Modern Laboratory Medicine,2018,33(03):31.[doi:10.3969/j.issn.1671-7414.2018.04.008]
[4]林文科,吴吉芳,郑志昂.非小细胞肺癌患者血清miR-141及miR-224的表达及其临床意义[J].现代检验医学杂志,2018,33(02):46.[doi:10.3969/j.issn.1671-7414.2018.02.001]
　LIN Wen-ke,WU Ji-fang,ZHENG Zhi-ang.Expression of Serum miR-141 and miR-224 in Patients with Non-Small Cell Lung Cancer and Its Clinical Significance[J].Journal of Modern Laboratory Medicine,2018,33(03):46.[doi:10.3969/j.issn.1671-7414.2018.02.001]
[5]邝美华,陈意珊,石亚玲.血小板与淋巴细胞比值对非小细胞肺癌预后评估的Meta分析[J].现代检验医学杂志,2018,33(03):112.[doi:10.3969/j.issn.1671-7414.2018.03.028]
　KUANG Mei-hua,CHEN Yi-shan,SHI Ya-ling.Prognostic Value of Platelet to Lymphocyte Ratio in Non-Small Cell Lung Cancer:a Meta-analysis[J].Journal of Modern Laboratory Medicine,2018,33(03):112.[doi:10.3969/j.issn.1671-7414.2018.03.028]
[6]苗留飞,杨 阳,余柏增,等.三代EGFR-TKI奥希替尼(AZD9291)耐药细胞系建立及耐药标志预测分析[J].现代检验医学杂志,2019,34(05):28.[doi:10.3969/j.issn.1671-7414.2019.05.008]
　MIAO Liu-fei,YANG Yang,YU Bai-zeng,et al.Establishment of the Third Generation of EGFR-TKI Resistant CellLine and Resistance Gene Signature[J].Journal of Modern Laboratory Medicine,2019,34(03):28.[doi:10.3969/j.issn.1671-7414.2019.05.008]
[7]王　旋,崔立春,党升强.非小细胞肺癌放化疗联合靶向治疗对血清肿瘤标志物、免疫功能及CyclinD3水平影响的相关研究[J].现代检验医学杂志,2021,36(04):25.[doi:10.3969/j.issn.1671-7414.2021.04.006]
　WANG Xuan,CUI Li-chun,DANG Sheng-qiang.Effects of Radiotherapy and Chemotherapy Combined with Targeted Therapy onSerum Tumor Markers, Immune Function and CyclinD3 Level inNon-Small Cell Lung Cancer[J].Journal of Modern Laboratory Medicine,2021,36(03):25.[doi:10.3969/j.issn.1671-7414.2021.04.006]

备注/Memo

备注/Memo:
基金项目:南通市卫生局青年科学基金资助项目(WQ2014010,WQ2015021); 南通市科技项目(HS2014060)。 作者简介:陈 相(1974-),女,硕士研究生,副主任医师,主要从事免疫学研究,Tel:13809088303,E-mail:ntchenx0520@163.com。 通讯作者:曹兴建(1963-),男,主任技师,E-mail:ntcaoxh@163.com。
更新日期/Last Update: 2016-06-25